-
May 22, 2012
A market pullback can lead to stocks being on sale.
-
May 02, 2012
Allergan Beats on Revs, Misses on EPS - Analyst Blog
-
May 01, 2012
Rockin' REITs
-
May 01, 2012
Earnings Preview: Allergan - Analyst Blog
-
March 30, 2012
Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates ...
-
November 10, 2011
Medicis is well-run, but arguably too risky to stay independent.
-
November 07, 2011
The beauty industry continues to do well in a volatile market.
-
June 30, 2011
As the search for income continues, the mortgage REIT sub-sector could be just what investors are looking for.
-
June 30, 2011
Recently, three strong factors are driving investors to the drug sector.
-
May 24, 2011
Obagi's stock dropped 24% after announcing a 13-cent loss in its first quarter. Find out why this presents an ...
-
March 23, 2011
Little-known American Capital Agency is a REIT that investors should consider - with the right diversification.
-
March 02, 2011
Medicis gets a big boost from patent settlements.
-
February 18, 2011
Not all dividend yields are equal. Yet today, there are several securities paying above average double-digit yields.
-
December 16, 2010
Novartis closes the deal for Alcon.
-
November 12, 2010
With minimal expectations in the stock price, just a little growth at Covidien could make it a market-beater.
-
November 03, 2010
Allergan's earnings aren't special, but the stock is basking in Wall Street's love. Is it simply a case of lipstick ...
-
September 23, 2010
Investors searching for high yields often overlook sectors such as MLPs.
-
September 03, 2010
Pure-play aesthetics companies have been hit hard by the recession, but does the desire for beauty ever go away for ...
-
July 28, 2010
The Sanofi/Genzyme combination isn't the only biotech M&A activity on the radar.
-
January 11, 2010
The Swiss drug maker hopes to take full ownership of Alcon later in the year. Find out what it'll mean for these two ...
